- Home
- NEGG vs IOBT Comparison
NEGG vs IOBT Comparison
Compare NEGG & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- IOBT
- Stock Information
- Founded
- NEGG 2001
- IOBT 2014
- Country
- NEGG United States
- IOBT Denmark
- Employees
- NEGG N/A
- IOBT N/A
- Industry
- NEGG Other Specialty Stores
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- IOBT Health Care
- Exchange
- NEGG Nasdaq
- IOBT Nasdaq
- Market Cap
- NEGG 75.6M
- IOBT 62.6M
- IPO Year
- NEGG 2010
- IOBT 2021
- Fundamental
- Price
- NEGG $4.01
- IOBT $1.00
- Analyst Decision
- NEGG
- IOBT Strong Buy
- Analyst Count
- NEGG 0
- IOBT 3
- Target Price
- NEGG N/A
- IOBT $9.33
- AVG Volume (30 Days)
- NEGG 33.3K
- IOBT 83.8K
- Earning Date
- NEGG 04-28-2025
- IOBT 05-20-2025
- Dividend Yield
- NEGG N/A
- IOBT N/A
- EPS Growth
- NEGG N/A
- IOBT N/A
- EPS
- NEGG N/A
- IOBT N/A
- Revenue
- NEGG $1,235,576,000.00
- IOBT N/A
- Revenue This Year
- NEGG N/A
- IOBT N/A
- Revenue Next Year
- NEGG N/A
- IOBT N/A
- P/E Ratio
- NEGG N/A
- IOBT N/A
- Revenue Growth
- NEGG N/A
- IOBT N/A
- 52 Week Low
- NEGG $3.32
- IOBT $0.66
- 52 Week High
- NEGG $26.40
- IOBT $1.79
- Technical
- Relative Strength Index (RSI)
- NEGG 45.45
- IOBT 52.54
- Support Level
- NEGG $3.40
- IOBT $0.95
- Resistance Level
- NEGG $4.20
- IOBT $1.20
- Average True Range (ATR)
- NEGG 0.31
- IOBT 0.09
- MACD
- NEGG 0.14
- IOBT 0.01
- Stochastic Oscillator
- NEGG 77.84
- IOBT 43.10
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.